• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸临床I期非精原细胞性生殖细胞肿瘤的预后因素

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

作者信息

Raghavan D, Peckham M J, Heyderman E, Tobias J S, Austin D E

出版信息

Br J Cancer. 1982 Feb;45(2):167-73. doi: 10.1038/bjc.1982.29.

DOI:10.1038/bjc.1982.29
PMID:6174137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2010890/
Abstract

Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified which showed a significant correlation with relapse following radiotherapy: local extent of the primary tumour, and rate of decline of serum alpha-foetoprotein (AFP) and beta-human chorionic gonadotrophin (hCG) levels following orchidectomy. High serum marker levels at the time of referral after orchidectomy were not prognostically significant per se. The presence of tissue-associated hCG in the primary tumour was not prognostically significant. The results were compared with histology and pathological stage of the primary tumour in patients presenting with lung metastases but no clinical evidence of lymph-node disease. Embryonal carcinoma was more commonly associated with a locally invasive primary tumour and with extralymphatic spread than was teratocarcinoma.

摘要

对1973年至1978年间在皇家马斯登医院就诊的59例临床I期睾丸非精原细胞瘤(NSGCTT)男性患者的预后因素进行了研究。14例患者复发,45例持续无病。确定了两个与放疗后复发显著相关的因素:原发肿瘤的局部范围,以及睾丸切除术后血清甲胎蛋白(AFP)和β-人绒毛膜促性腺激素(hCG)水平的下降速率。睾丸切除术后转诊时血清标志物水平高本身并无预后意义。原发肿瘤中组织相关hCG的存在并无预后意义。将结果与出现肺转移但无淋巴结疾病临床证据的患者的原发肿瘤组织学和病理分期进行了比较。与畸胎癌相比,胚胎癌更常与局部浸润性原发肿瘤和淋巴外扩散相关。

相似文献

1
Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.睾丸临床I期非精原细胞性生殖细胞肿瘤的预后因素
Br J Cancer. 1982 Feb;45(2):167-73. doi: 10.1038/bjc.1982.29.
2
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Br J Urol. 1981 Apr;53(2):162-72. doi: 10.1111/j.1464-410x.1981.tb03160.x.
3
Tumour-marker levels and prognosis in malignant teratoma of the testis.睾丸恶性畸胎瘤的肿瘤标志物水平与预后
Br J Cancer. 1980 Dec;42(6):850-5. doi: 10.1038/bjc.1980.332.
4
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
Lancet. 1982 Sep 25;2(8300):678-80. doi: 10.1016/s0140-6736(82)90710-3.
5
Testicular tumour markers in tissue correlated to serum levels and clinical stage.组织中的睾丸肿瘤标志物与血清水平及临床分期相关。
Scand J Urol Nephrol. 1984;18(4):283-8. doi: 10.3109/00365598409180197.
6
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.
J Clin Oncol. 1984 Apr;2(4):267-70. doi: 10.1200/JCO.1984.2.4.267.
7
Single institutional experience with non-seminomatous germ cell tumours of the testis: local perspectives on a curable cancer.
Aust N Z J Med. 1991 Dec;21(6):857-62. doi: 10.1111/j.1445-5994.1991.tb01407.x.
8
Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.评估五种肿瘤标志物(甲胎蛋白、癌胚抗原、人绒毛膜促性腺激素、人胎盘催乳素和妊娠相关血浆蛋白A)在监测睾丸生殖细胞肿瘤患者的治疗及随访中的作用。
Oncology. 1983;40(1):1-10. doi: 10.1159/000225681.
9
Tumor markers in patients with non-seminomatous germ cell tumors of the testis.睾丸非精原细胞瘤患者的肿瘤标志物
Oncodev Biol Med. 1981;2(1-2):117-28.
10
Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.早期血清肿瘤标志物半衰期在转移性睾丸畸胎瘤中的预后意义
J Clin Oncol. 1995 Jan;13(1):87-92. doi: 10.1200/JCO.1995.13.1.87.

引用本文的文献

1
Current Concepts in Management of Stage I NSGCT.I期非精原细胞瘤性生殖细胞肿瘤的管理现状
Indian J Surg Oncol. 2017 Mar;8(1):51-58. doi: 10.1007/s13193-016-0588-z. Epub 2016 Dec 17.
2
Advances in pathology and immunocytochemistry.病理学与免疫细胞化学的进展
J R Soc Med. 1985;78 Suppl 6(Suppl 6):9-18.
3
Tumour markers in testicular cancer.睾丸癌中的肿瘤标志物
J R Soc Med. 1985;78 Suppl 6(Suppl 6):19-24.

本文引用的文献

1
Evaluation of computed tomography in the management of testicular teratoma.
Br J Urol. 1981 Apr;53(2):179-83. doi: 10.1111/j.1464-410x.1981.tb03162.x.
2
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Br J Urol. 1981 Apr;53(2):162-72. doi: 10.1111/j.1464-410x.1981.tb03160.x.
3
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.需要对每位患者进行长期观察的随机临床试验的设计与分析。I. 引言与设计。
Br J Cancer. 1976 Dec;34(6):585-612. doi: 10.1038/bjc.1976.220.
4
An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy.
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1653-8.
5
Immunoperoxidase technique in histopathology: applications, methods, and controls.组织病理学中的免疫过氧化物酶技术:应用、方法与对照
J Clin Pathol. 1979 Oct;32(10):971-8. doi: 10.1136/jcp.32.10.971.
6
Combined management of malignant teratoma of the testis.
Lancet. 1979 Aug 11;2(8137):267-70. doi: 10.1016/s0140-6736(79)90288-5.
7
Letter: Syncytiotrophoblasts in malignant testicular tumours.
Lancet. 1976 Jul 10;2(7976):103. doi: 10.1016/s0140-6736(76)92325-4.